Prognostic value of chronic kidney disease after transcatheter aortic valve implantation

Masanori Yamamoto, Kentaro Hayashida, Gauthier Mouillet, Thomas Hovasse, Bernard Chevalier, Atsushi Oguri, Yusuke Watanabe, Jean Luc Dubois-Randé, Marie Claude Morice, Thierry Lefèvre, Emmanuel Teiger

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Objectives This study sought to assess the influence of chronic kidney disease (CKD) classification on clinical outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). Background The prognostic value of impaired renal function according to CKD classification has not been thoroughly investigated in very elderly TAVI cohorts. Methods Data from 642 consecutive patients who underwent TAVI were prospectively collected. Clinical outcomes were compared in enrolled patients, divided into CKD stage 1+2, CKD stage 3a, CKD stage 3b, and CKD stage 4 on the basis of estimated glomerular filtration rate ≥60, 45 to 59, 30 to 44, and 15 to 29 ml/min/1.73 m 2, respectively. Results Among the study patients (mean age: 83.5 ± 6.5 years, logistic European System for Cardiac Operative Risk Evaluation score 20.0% [range: 13.6% to 28.8%]), 34% were categorized as CKD stage 1+2 (n = 218), 28.3% as CKD stage 3a (n = 182), 28.2% as CKD stage 3b (n = 181), and 9.5% as CKD stage 4 (n = 61). Thirty-day and cumulative 1-year mortality rates increased significantly across the 4 groups (6.9% vs. 8.8% vs. 13.3% vs. 26.2%, p = 0.002, and 17.2% vs. 23.4% vs. 29.2% vs. 47.8%, p < 0.001, respectively). After adjustment for considerable influential confounders in a Cox multivariate regression model, CKD stage 4 was associated with increased risk for 30-day mortality (hazard ratio: 3.04; 95% confidence interval [CI]: 1.43 to 6.49; p = 0.004), and CKD stages 3b and 4 were related to increased cumulative 1-year mortality (hazard ratios: 1.71 and 2.91; 95% CI: 1.09 to 2.68 and 1.73 to 4.90; p = 0.020 and p < 0.001, respectively) compared with CKD stage 1+2 as the referent. Conclusions Classification of CKD stages before TAVI allows risk stratification for early and midterm clinical outcomes. TAVI for patients with CKD stage 4 is still considered challenging because of high mortality rates after the procedure.

Original languageEnglish
Pages (from-to)869-877
Number of pages9
JournalJournal of the American College of Cardiology
Volume62
Issue number10
DOIs
Publication statusPublished - 2013 Sep 3
Externally publishedYes

Fingerprint

Chronic Renal Insufficiency
Mortality
Transcatheter Aortic Valve Replacement
Confidence Intervals
Glomerular Filtration Rate

Keywords

  • chronic kidney disease
  • prognosis
  • transcatheter aortic valve implantation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Yamamoto, M., Hayashida, K., Mouillet, G., Hovasse, T., Chevalier, B., Oguri, A., ... Teiger, E. (2013). Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. Journal of the American College of Cardiology, 62(10), 869-877. https://doi.org/10.1016/j.jacc.2013.04.057

Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. / Yamamoto, Masanori; Hayashida, Kentaro; Mouillet, Gauthier; Hovasse, Thomas; Chevalier, Bernard; Oguri, Atsushi; Watanabe, Yusuke; Dubois-Randé, Jean Luc; Morice, Marie Claude; Lefèvre, Thierry; Teiger, Emmanuel.

In: Journal of the American College of Cardiology, Vol. 62, No. 10, 03.09.2013, p. 869-877.

Research output: Contribution to journalArticle

Yamamoto, M, Hayashida, K, Mouillet, G, Hovasse, T, Chevalier, B, Oguri, A, Watanabe, Y, Dubois-Randé, JL, Morice, MC, Lefèvre, T & Teiger, E 2013, 'Prognostic value of chronic kidney disease after transcatheter aortic valve implantation', Journal of the American College of Cardiology, vol. 62, no. 10, pp. 869-877. https://doi.org/10.1016/j.jacc.2013.04.057
Yamamoto, Masanori ; Hayashida, Kentaro ; Mouillet, Gauthier ; Hovasse, Thomas ; Chevalier, Bernard ; Oguri, Atsushi ; Watanabe, Yusuke ; Dubois-Randé, Jean Luc ; Morice, Marie Claude ; Lefèvre, Thierry ; Teiger, Emmanuel. / Prognostic value of chronic kidney disease after transcatheter aortic valve implantation. In: Journal of the American College of Cardiology. 2013 ; Vol. 62, No. 10. pp. 869-877.
@article{f441701607fb44058a2f0cd98b6fb48f,
title = "Prognostic value of chronic kidney disease after transcatheter aortic valve implantation",
abstract = "Objectives This study sought to assess the influence of chronic kidney disease (CKD) classification on clinical outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). Background The prognostic value of impaired renal function according to CKD classification has not been thoroughly investigated in very elderly TAVI cohorts. Methods Data from 642 consecutive patients who underwent TAVI were prospectively collected. Clinical outcomes were compared in enrolled patients, divided into CKD stage 1+2, CKD stage 3a, CKD stage 3b, and CKD stage 4 on the basis of estimated glomerular filtration rate ≥60, 45 to 59, 30 to 44, and 15 to 29 ml/min/1.73 m 2, respectively. Results Among the study patients (mean age: 83.5 ± 6.5 years, logistic European System for Cardiac Operative Risk Evaluation score 20.0{\%} [range: 13.6{\%} to 28.8{\%}]), 34{\%} were categorized as CKD stage 1+2 (n = 218), 28.3{\%} as CKD stage 3a (n = 182), 28.2{\%} as CKD stage 3b (n = 181), and 9.5{\%} as CKD stage 4 (n = 61). Thirty-day and cumulative 1-year mortality rates increased significantly across the 4 groups (6.9{\%} vs. 8.8{\%} vs. 13.3{\%} vs. 26.2{\%}, p = 0.002, and 17.2{\%} vs. 23.4{\%} vs. 29.2{\%} vs. 47.8{\%}, p < 0.001, respectively). After adjustment for considerable influential confounders in a Cox multivariate regression model, CKD stage 4 was associated with increased risk for 30-day mortality (hazard ratio: 3.04; 95{\%} confidence interval [CI]: 1.43 to 6.49; p = 0.004), and CKD stages 3b and 4 were related to increased cumulative 1-year mortality (hazard ratios: 1.71 and 2.91; 95{\%} CI: 1.09 to 2.68 and 1.73 to 4.90; p = 0.020 and p < 0.001, respectively) compared with CKD stage 1+2 as the referent. Conclusions Classification of CKD stages before TAVI allows risk stratification for early and midterm clinical outcomes. TAVI for patients with CKD stage 4 is still considered challenging because of high mortality rates after the procedure.",
keywords = "chronic kidney disease, prognosis, transcatheter aortic valve implantation",
author = "Masanori Yamamoto and Kentaro Hayashida and Gauthier Mouillet and Thomas Hovasse and Bernard Chevalier and Atsushi Oguri and Yusuke Watanabe and Dubois-Rand{\'e}, {Jean Luc} and Morice, {Marie Claude} and Thierry Lef{\`e}vre and Emmanuel Teiger",
year = "2013",
month = "9",
day = "3",
doi = "10.1016/j.jacc.2013.04.057",
language = "English",
volume = "62",
pages = "869--877",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "10",

}

TY - JOUR

T1 - Prognostic value of chronic kidney disease after transcatheter aortic valve implantation

AU - Yamamoto, Masanori

AU - Hayashida, Kentaro

AU - Mouillet, Gauthier

AU - Hovasse, Thomas

AU - Chevalier, Bernard

AU - Oguri, Atsushi

AU - Watanabe, Yusuke

AU - Dubois-Randé, Jean Luc

AU - Morice, Marie Claude

AU - Lefèvre, Thierry

AU - Teiger, Emmanuel

PY - 2013/9/3

Y1 - 2013/9/3

N2 - Objectives This study sought to assess the influence of chronic kidney disease (CKD) classification on clinical outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). Background The prognostic value of impaired renal function according to CKD classification has not been thoroughly investigated in very elderly TAVI cohorts. Methods Data from 642 consecutive patients who underwent TAVI were prospectively collected. Clinical outcomes were compared in enrolled patients, divided into CKD stage 1+2, CKD stage 3a, CKD stage 3b, and CKD stage 4 on the basis of estimated glomerular filtration rate ≥60, 45 to 59, 30 to 44, and 15 to 29 ml/min/1.73 m 2, respectively. Results Among the study patients (mean age: 83.5 ± 6.5 years, logistic European System for Cardiac Operative Risk Evaluation score 20.0% [range: 13.6% to 28.8%]), 34% were categorized as CKD stage 1+2 (n = 218), 28.3% as CKD stage 3a (n = 182), 28.2% as CKD stage 3b (n = 181), and 9.5% as CKD stage 4 (n = 61). Thirty-day and cumulative 1-year mortality rates increased significantly across the 4 groups (6.9% vs. 8.8% vs. 13.3% vs. 26.2%, p = 0.002, and 17.2% vs. 23.4% vs. 29.2% vs. 47.8%, p < 0.001, respectively). After adjustment for considerable influential confounders in a Cox multivariate regression model, CKD stage 4 was associated with increased risk for 30-day mortality (hazard ratio: 3.04; 95% confidence interval [CI]: 1.43 to 6.49; p = 0.004), and CKD stages 3b and 4 were related to increased cumulative 1-year mortality (hazard ratios: 1.71 and 2.91; 95% CI: 1.09 to 2.68 and 1.73 to 4.90; p = 0.020 and p < 0.001, respectively) compared with CKD stage 1+2 as the referent. Conclusions Classification of CKD stages before TAVI allows risk stratification for early and midterm clinical outcomes. TAVI for patients with CKD stage 4 is still considered challenging because of high mortality rates after the procedure.

AB - Objectives This study sought to assess the influence of chronic kidney disease (CKD) classification on clinical outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). Background The prognostic value of impaired renal function according to CKD classification has not been thoroughly investigated in very elderly TAVI cohorts. Methods Data from 642 consecutive patients who underwent TAVI were prospectively collected. Clinical outcomes were compared in enrolled patients, divided into CKD stage 1+2, CKD stage 3a, CKD stage 3b, and CKD stage 4 on the basis of estimated glomerular filtration rate ≥60, 45 to 59, 30 to 44, and 15 to 29 ml/min/1.73 m 2, respectively. Results Among the study patients (mean age: 83.5 ± 6.5 years, logistic European System for Cardiac Operative Risk Evaluation score 20.0% [range: 13.6% to 28.8%]), 34% were categorized as CKD stage 1+2 (n = 218), 28.3% as CKD stage 3a (n = 182), 28.2% as CKD stage 3b (n = 181), and 9.5% as CKD stage 4 (n = 61). Thirty-day and cumulative 1-year mortality rates increased significantly across the 4 groups (6.9% vs. 8.8% vs. 13.3% vs. 26.2%, p = 0.002, and 17.2% vs. 23.4% vs. 29.2% vs. 47.8%, p < 0.001, respectively). After adjustment for considerable influential confounders in a Cox multivariate regression model, CKD stage 4 was associated with increased risk for 30-day mortality (hazard ratio: 3.04; 95% confidence interval [CI]: 1.43 to 6.49; p = 0.004), and CKD stages 3b and 4 were related to increased cumulative 1-year mortality (hazard ratios: 1.71 and 2.91; 95% CI: 1.09 to 2.68 and 1.73 to 4.90; p = 0.020 and p < 0.001, respectively) compared with CKD stage 1+2 as the referent. Conclusions Classification of CKD stages before TAVI allows risk stratification for early and midterm clinical outcomes. TAVI for patients with CKD stage 4 is still considered challenging because of high mortality rates after the procedure.

KW - chronic kidney disease

KW - prognosis

KW - transcatheter aortic valve implantation

UR - http://www.scopus.com/inward/record.url?scp=84883248158&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84883248158&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2013.04.057

DO - 10.1016/j.jacc.2013.04.057

M3 - Article

C2 - 23707321

AN - SCOPUS:84883248158

VL - 62

SP - 869

EP - 877

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 10

ER -